ClinConnect ClinConnect Logo
Search / Trial NCT00768820

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

Launched by THE CHAIM SHEBA MEDICAL CENTER · Oct 7, 2008

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Velocardiofacial Syndrome Williams Syndrome Fragile X Syndrome Cognitive Phenotype Psychiatric Phenotype

ClinConnect Summary

This clinical trial is studying how certain conditions, specifically Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS), and Fragile X Syndrome, affect mental health and thinking abilities. Researchers want to understand the differences in psychiatric and cognitive traits among individuals with these syndromes. They will also look at how development and genetic factors might play a role in these conditions.

If you or a family member has been diagnosed with VCFS and has a confirmed chromosomal deletion identified through a specific test called FISH, you may be eligible to participate in this study. Participants will be involved in assessments that help researchers learn more about these syndromes, which may lead to better treatments in the future. This study is currently recruiting individuals of all ages and genders, and your participation could make a significant difference in understanding these complex conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • chromosomal deletion proven by FISH examination
  • Exclusion Criteria:

About The Chaim Sheba Medical Center

The Chaim Sheba Medical Center, Israel's largest and most comprehensive medical institution, is renowned for its commitment to advancing healthcare through innovative clinical research and trials. Affiliated with Tel Aviv University, Sheba integrates cutting-edge medical care with pioneering research initiatives, fostering a multidisciplinary approach to patient treatment and disease prevention. With a focus on translating scientific discoveries into clinical applications, the center actively engages in a wide range of studies across various medical fields, aiming to enhance therapeutic outcomes and improve patient quality of life. Its state-of-the-art facilities and expert medical team position Sheba as a leader in the global clinical research landscape.

Locations

Petach Tikva, , Israel

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials